Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 713, pseudogene (RNU6-713P) is a genetic sequence found in the human genome derived from U6 small nuclear RNA (snRNA), one of several snRNAs vital for eukaryotic mRNA splicing. RNU6-713P is classified as a pseudogene, meaning it has lost the ability to encode a functional RNA due to mutations or insertional events. While canonical U6 snRNA is essential for spliceosome formation and function[1][5], pseudogenes like RNU6-713P do not contribute actively to biological processes and are not considered therapeutic targets. Pseudogenes may sometimes play regulatory roles or be markers of evolutionary processes, but thereS_no_evidence_that_RNU6-713P_is_involved_in_any_specific_biological_function_or_disease,_nor_is_it_a_target_for_drug_therapy[2][7].
Not applicable. No drugs target this pseudogene, and it does not encode functional biomolecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 713, pseudogene (RNU6-713P).